Close Menu

BGI

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Merck and BGI announced today that they will collaborate on the discovery and development of biomarkers and other genomic technologies.

BGI and Diagenode will collaborate to develop standard methods in sample prep for next-generation sequencing for epigenetics research, the companies said today.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – BGI and Diagenode are collaborating to implement standard methods in epigenetics and next-generation sequencing sample preparation.

Officials from both organizations said this week that they are keen to use Exonhit's SpliceArray platform in new, sequencing-driven biomarker discovery projects.

Researchers using exome sequencing to study ADHD found rare mutations they think may be causing a patient's anemia, raising the question of how to handle unrelated findings in sequencing studies.

In a proof-of-concept paper, the BGI team demonstrated that it is possible to call structural variations from short-read sequencing data by using de novo assembly instead of alignment to a reference genome.

The project combines BGI's next-generation sequencing and Exonhit's SpliceArray technologies to expand the SpliceArray platform to an additional "strategic preclinical animal model species."

The project aims to sequence the genomes of 1,000 plant and animal that hold scientific and economic importance. It expects to have 200 species sequenced and assembled by the end of the year.

Under the deal, BGI will use Covaris' LE220 instrument and consumables as part of its library construction process for next-generation sequencing at several of its laboratories.

New Products: Jul 12, 2011

Premium

Ion Torrent's 316 chip, BGI's SOAP software

Pages

23andMe is offering early customers re-testing on newer chips for a fee, Wired reports.

He Jiankui is no longer affiliated with Direct Genomics Biotechnology, the single molecule sequencing company he founded, Nikkei Asian Review reports.

Newsweek writes about the hopes for precision medicine in cancer, but also challenges getting it to patients.

In Genome Research this week: genomic architecture of glioblastoma, predictive computational approach to estimate SNP fitness, and more.